Healio Gastroenterology, June 2017
Familial chylomicronemia syndrome (FCS) is a rare and potentially life-threatening genetic disease. The clinical hallmark of FCS is pancreatitis associated with marked chylomicronemia and triglyceridemia. It is important that gastroenterologists recognize the signs and symptoms to properly evaluate, as well as manage, patients with FCS. In this activity, a gastroenterologist will review the diagnosis, assessment, management, ongoing challenges, and future therapeutic options for patients with FCS.
Upon successful completion of this educational activity, participants should be better able to:
- Assess the burden of FCS, its pathophysiology, and the importance of early diagnosis and treatment.
- Describe the clinical symptomatology associated with FCS, as well as diagnostic modalities that assist in earlier diagnosis.
- Evaluate the use of dietary modifications for the management of FCS based on efficacy and impact on patient quality-of-life.
- Recognize the benefits and limitations of available and emerging therapeutic interventions for the management of FCS.